The chemical class of PITSLRE A activators encompasses a range of compounds that potentially influence the activity of PITSLRE A indirectly through their impact on various cellular signaling pathways and processes. PITSLRE A, being a serine/threonine-protein kinase, is involved in critical cellular functions, including the response to DNA damage and cell cycle regulation, making the modulation of its activity significant for understanding and potentially manipulating these processes. Compounds such as Caffeine, Staurosporine, and UCN-01 influence a variety of kinases and signaling pathways. Caffeine, by inhibiting ATM and ATR kinases, could lead to a compensatory activation of PITSLRE A in DNA damage response pathways. Staurosporine and its derivative UCN-01, as broad-spectrum kinase inhibitors, have the potential to modulate multiple pathways, indirectly affecting PITSLRE A activity. DNA-damaging agents like Etoposide and Camptothecin induce DNA damage, potentially activating PITSLRE A as part of the cellular response to DNA damage.
Other members of this class, including Hydroxyurea, Rapamycin, Roscovitine, and Olomoucine, influence cell cycle regulation and DNA replication, pathways in which PITSLRE A is implicated. Hydroxyurea, by inducing replication stress, and Rapamycin, through mTOR inhibition, may alter cell cycle dynamics, potentially leading to PITSLRE A activation. Roscovitine and Olomoucine, as CDK inhibitors, also impact cell cycle regulation, possibly influencing PITSLRE A activity. Compounds such as SP600125 and PD98059, by modulating JNK and MEK pathways, respectively, could cause compensatory effects in other kinases, including PITSLRE A. Lastly, LY294002, a PI3K inhibitor, could affect PITSLRE A through its impact on signaling cascades related to cell growth and survival.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Inhibits ATM and ATR kinases, potentially leading to compensatory activation of PITSLRE A in DNA damage response pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor that may affect multiple pathways, indirectly modulating PITSLRE A activity. | ||||||
UCN-01 | 112953-11-4 | sc-202376 | 500 µg | $251.00 | 10 | |
Inhibits several kinases and might influence PITSLRE A activity through altered cellular signaling. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Induces DNA damage, potentially activating PITSLRE A as part of the DNA damage response. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Causes DNA damage and may indirectly activate PITSLRE A through DNA damage response pathways. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Induces replication stress, potentially leading to activation of PITSLRE A in response to DNA replication issues. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, potentially leading to changes in cell cycle regulation that may activate PITSLRE A. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Inhibits cyclin-dependent kinases (CDKs), potentially influencing PITSLRE A activity in cell cycle regulation. | ||||||
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
Another CDK inhibitor that may affect PITSLRE A through modulation of the cell cycle. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, possibly causing compensatory activation of other kinases, including PITSLRE A. | ||||||